Inventor · disambiguated record
Weihsu Claire Chen
Also filed as: CHEN WEIHSU · CHEN WEIHSU CLAIRE
8 granted patents·6 pending applications·143 citations·filing 2008–2025
87Inventor score
Top patents by PatentIndex Score
14 records- 0194US11801257B2Stimulation of an immune response by enantiomers of cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2020·Granted Oct 31, 2023·4 cites·13 claims
- 0292US10702541B2Stimulation of an immune response by enantiomers of cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2017·Granted Jul 7, 2020·7 cites·13 claims
- 0392US8877206B2Stimulation of an immune response by cationic lipidsCHEN WEIHSU·Filed 2008·Granted Nov 4, 2014·78 cites·44 claims
- 0489US9326939B2Liposome targeting compounds and related usesPAULSON JAMES C·Filed 2011·Granted May 3, 2016·42 cites·7 claims
- 0583US11911359B2Stimulation of an immune response by cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2014·Granted Feb 27, 2024·2 cites·21 claims
- 0683US9789129B2Stimulation of an immune response by enantiomers of cationic lipidsVASIEVICH ELIZABETH ANN·Filed 2009·Granted Oct 17, 2017·10 cites·4 claims
- 0771US2021346333A1Stimulation of an immune response by cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 0871US2022031650A1Stimulation of an immune response by cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 0969US2021308157A1Stimulation of an immune response by enantiomers of cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 1062US2025333536A1Mageb2 binding constructsAMGEN INC·Filed 2025·Application pending·0 cites
- 1159US2025277029A1Cannabinoid type 1 receptor binding proteins and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 1258US12312412B2MAGEB2 binding constructsAMGEN INC·Filed 2021·Granted May 27, 2025·0 cites·11 claims
- 1347US11111542B2Method for identifying high-risk AML patientsUNIV HEALTH NETWORK·Filed 2017·Granted Sep 7, 2021·0 cites·5 claims
- 1447US2023314417A1Monoclonal antibodies to chemically-modified nucleic acids and uses thereofAMGEN INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →